Testing glucose tolerance right after childbirth
Official title: Immediate Postpartum Glucose Tolerance Testing Among Gestational Diabetics: A Comparison to the Gold Standard
Run by MemorialCare Health System · NCT04199676 · Data updated 2026-11-12
This study is trying to see if testing blood sugar right after childbirth can help women with gestational diabetes get better care and catch any ongoing issues sooner than the usual test done six weeks later.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 300 (estimated) |
| Sponsor | MemorialCare Health System Academic / other |
| Locations | 1 site (Long Beach, California) |
| Status | Recruiting |
| Started | September 1, 2020 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | September 3, 2025 |
| Trial ID | NCT04199676 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are women who are pregnant or have recently given birth (postpartum day 0 or 1) and have been diagnosed with gestational diabetes.
✕Probably not a fit
Patients who are medically excluded from completing glucose tolerance testing or those who have received steroid treatment within 10 days prior to enrollment may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study compares the accuracy of a two-hour glucose tolerance test conducted during postpartum hospitalization with the standard glucose tolerance test performed six weeks after delivery. It aims to determine if testing immediately postpartum can improve compliance rates among women diagnosed with gestational diabetes. The study will capture data on women with gestational diabetes to assess the effectiveness of immediate testing in identifying those with persistent glucose intolerance. By addressing low compliance rates, the study seeks to enhance early diagnosis and treatment opportunities for women at risk of developing type 2 diabetes.
Why it matters
Potential benefit: If successful, this approach could lead to earlier identification and management of glucose intolerance in postpartum women, reducing the risk of developing type 2 diabetes.
How similar studies have gone: While the approach of immediate postpartum glucose testing is innovative, similar studies have not been widely reported, indicating this may be a novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant or recently postpartum (postpartum day 0 or 1) * ≥ 18 years of age * Gestational age ≥34 weeks * A1 or A2 gestational diabetes Exclusion Criteria: * Medical exclusion from completing glucose tolerance testing * Steroid administration within 10 days prior to enrollment * Chronic steroid use
Where it's running
-
Long Beach Memorial Medical Center/Miller Children's and Women's Hospital
Long Beach, California, United States Recruiting
Study contacts
- Principal investigator: Alice Sherman-Brown, MD — Magella Medical Group
- Study coordinator: Alice Sherman-Bron, MD
- Email: alicebrown092@gmail.com
- Phone: (562) 997-8510
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Early Glucose Patterns in Pregnant Women at Risk for GDM
This study tests whether continuous glucose monitoring in early pregnancy can detect dysglycemia before GDM is diagnosed, in women with and without known risk factors.
-
Probiotic-augmented therapy for gestational diabetes
This trial tests whether adding multistrain probiotics to metformin, insulin, or their combination can improve blood sugar control and inflammation in pregnant women with gestational diabetes.
-
Maternal insulin and fat metabolism in pregnancies at risk for preeclampsia and gestational diabetes
This project will try to see if insulin resistance and how the body burns fats early in pregnancy predict later preeclampsia or gestational diabetes in people at higher risk.
-
How sleep, lifestyle, and metabolism relate to pregnancy outcomes in gestational diabetes
This project will see if sleep quality, anxiety, eating and activity habits, and metabolic markers relate to blood sugar control and birth outcomes in pregnant people with gestational diabetes.
-
Pre-eclampsia risk in pregnancies after oocyte donation
We will follow pregnant women who used donated eggs and women who used their own eggs to see if pregnancies after oocyte donation lead to a higher risk of pre-eclampsia.
-
Mobile-based obstetric monitoring for hypertension and diabetes during pregnancy
A mobile app-based program lets pregnant people with high blood pressure or gestational diabetes track BP and glucose at home and share results with their care team to guide care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.